普洛药业：2025年前三季度净利润同比减少19.48%

Core Viewpoint - The company reported a decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company achieved an operating revenue of 7.764 billion yuan, representing a year-on-year decrease of 16.43% [1] - The net profit attributable to shareholders was 700 million yuan, down 19.48% year-on-year [1] - Basic earnings per share were 0.6063 yuan, reflecting an 18.79% decline compared to the same period last year [1]